Brannan Stephen K.
SEC Form 4 insider trading activity
Brannan Stephen K. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jul 9, 2026.
On the most recent filing, Brannan Stephen K. is listed as Director at Serina Therapeutics, Inc. Inside the rolling window, Brannan Stephen K. reported 1 open-market purchase totaling $2K in SER and no open-market sales.
Companies traded
Other insiders at SER
Insider Buying
$2K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Brannan Stephen K. made?
Brannan Stephen K. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Brannan Stephen K. trade?
Brannan Stephen K. has filed SEC Form 4 disclosures for 1 company, including SER.
When was Brannan Stephen K.'s most recent SEC Form 4 filing?
Brannan Stephen K.'s most recent SEC Form 4 filing on Tracefour is dated Jul 9, 2026.
What is Brannan Stephen K.'s total buy and sell value in the current window?
Inside the rolling retention window, Brannan Stephen K. bought $2K and sold $0 based on SEC Form 4 filings.
What was Brannan Stephen K.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,000 SER shares on 2026-07-07, worth $2K, per SEC Form 4 filings.